185 related articles for article (PubMed ID: 12296182)
1. Choices: "the pill" combined oral contraceptive.
Contracept Technol Update; 2000 Sep; 21(9 Suppl):1-2. PubMed ID: 12296182
[TBL] [Abstract][Full Text] [Related]
2. [Oral contraception and its beneficial gynecological effects].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
[TBL] [Abstract][Full Text] [Related]
3. Pills remain the top choice among reversible contraceptive options.
Contracept Technol Update; 1999 Sep; 20(9):97-101. PubMed ID: 12290380
[TBL] [Abstract][Full Text] [Related]
4. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
[TBL] [Abstract][Full Text] [Related]
5. There's good news about birth control pills.
Contracept Technol Update; 1992 Oct; 13(10 Suppl):1-2. PubMed ID: 12288949
[TBL] [Abstract][Full Text] [Related]
6. Contraception and the big "C".
Chandran R
Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024
[TBL] [Abstract][Full Text] [Related]
7. Pill power: oral contraceptives hold top spot in family planning arsenal.
Contracept Technol Update; 1998 Oct; 19(10):125-7. PubMed ID: 12321842
[TBL] [Abstract][Full Text] [Related]
8. Clinicians choose distinctive approaches to OC management.
Contracept Technol Update; 1987 Sep; 8(9):118-20. PubMed ID: 12268913
[TBL] [Abstract][Full Text] [Related]
9. [Oral contraception: disadvantages of estrogen reduction].
Denis C
Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
[TBL] [Abstract][Full Text] [Related]
10. Contraceptive options for perimenopausal women.
Alexander IM
Contracept Technol Update; 1999 Oct; 20(10):122-4. PubMed ID: 12322323
[TBL] [Abstract][Full Text] [Related]
11. Birth control over 30.
Asnes M
Work Woman; 1994 Jul; ():68-70, 72, 84. PubMed ID: 12291485
[TBL] [Abstract][Full Text] [Related]
12. Notice, 13 March 1987.
United States. Food and Drug Administration FDA
Annu Rev Popul Law; 1987; 14():22. PubMed ID: 12346652
[TBL] [Abstract][Full Text] [Related]
13. FDA panel examines link between breast cancer, pill, says more research needed.
Wash Memo Alan Guttmacher Inst; 1989 Jan; ():3-4. PubMed ID: 12283353
[TBL] [Abstract][Full Text] [Related]
14. FDA opens door for emergency contraception.
Landovitz K
AVSC News; 1997; 35(2):7. PubMed ID: 12294488
[TBL] [Abstract][Full Text] [Related]
15. An update on the pill.
Initiatives Popul; 1983; 7(3):2-15. PubMed ID: 12339841
[TBL] [Abstract][Full Text] [Related]
16. Consider prescribing OCs for perimenopause use.
Contracept Technol Update; 2000 Mar; 21(3):31-3. PubMed ID: 12349548
[TBL] [Abstract][Full Text] [Related]
17. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
[TBL] [Abstract][Full Text] [Related]
18. Berlex introduces new 20 mcg birth control pill.
Contracept Technol Update; 1998 Nov; 19(11):145-6. PubMed ID: 12294211
[TBL] [Abstract][Full Text] [Related]
19. Might generic OCs create contraceptive price war?
Contracept Technol Update; 1987 Feb; 8(2):13-7. PubMed ID: 12314977
[TBL] [Abstract][Full Text] [Related]
20. Examine use of low- and lower-dose OCs.
Contracept Technol Update; 2000 Jun; 21(6):72-3. PubMed ID: 12295925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
